Labeed Diab was the CEO of ATI Physical Therapy, which he led through a critical merger in early 2021. His leadership came at a time when the healthcare industry faced numerous challenges. Diab's experience in healthcare is highlighted by his...

Labeed Diab was the CEO of ATI Physical Therapy, which he led through a critical merger in early 2021. His leadership came at a time when the healthcare industry faced numerous challenges. Diab's experience in healthcare is highlighted by his efforts to improve patient outcomes and push the company to adapt. In 2021, despite not meeting performance targets, he received a significant total compensation of $1.43 million, which included a discretionary bonus of $281,000 to reward effort during tough times. Interestingly, Diab's role was crucial during a transition period marked by a merger and change in business structure that required strong leadership. However, he stepped down in July 2021, after which he received substantial severance payments. His journey showcases the complexities of leading a company in the healthcare sector, balancing employee retention, and navigating the financial landscape during a challenging year.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other ATI Physical Therapy CEOs

A

Labeed Diab

Ex-CEO of ATI Physical Therapy

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

CEO of ATI Physical Therapy for

0 years 5 months (Feb 2021 - Jul 2021)

Previous Experience

Chief Executive Officer of the Company prior to the merger

Rivals

Competitors/colleagues of Labeed Diab

Holdings

See how much did Labeed Diab make over time.

While specific insider trading information is not detailed here, it's worth noting that Labeed Diab held a significant position during his time as CEO. In 2021, he was managing a complex compensation structure that included a significant deferred compensation plan,...

While specific insider trading information is not detailed here, it's worth noting that Labeed Diab held a significant position during his time as CEO. In 2021, he was managing a complex compensation structure that included a significant deferred compensation plan, likely reflecting his overall net worth tied to company performance. At the peak of his leadership, his compensation included a substantial deferred amount. Following his departure and with stock options not granted during his final year, there might have been fluctuations in his asset management as he transitioned away from the company, indicating a decrease in active management of ATI stock and a movement towards other investments or roles post-ATI. His strategic decisions before exiting suggest he ensured financial security, even as the company faced turbulence.

Loading...

Insider Trading

See recent insider trades of Labeed Diab.

No insider trades found for this CEO.

Compensation History

See how much did Labeed Diab make over time.

In 2021, Labeed Diab's total compensation was $1,432,892. His salary was set at $446,250, which is fairly standard for a CEO in the healthcare sector, especially given the complexities of leading during a merger. Diab earned a notable bonus of $281,000, which was recognized despite the company not hitting its EBITDA targets. His overall pay structure reflects both fixed and variable components, with a significant portion of 'other compensation' amounting to $710,642. This category included deferred payments from previous employment, demonstrating how past roles can impact current financial health. Diab's mix of base salary, bonus, and deferred compensation highlights a strategic approach designed to retain talent when the company faced difficult times. Overall, his compensation package mirrors the challenging environment he navigated.

Year

2021

Total Compensation

$1.44M

Salary

$446.25K

Board Justification

The compensation philosophy is designed to align total compensation with company performance, while enabling the attraction, retention, and motivation of executives who can achieve sustained long-term growth and strong financial performance for stockholders.

Bonus

$281.00K

Board Justification

Discretionary cash bonuses earned in 2021 were paid to retain bonus-eligible employees, including the above NEOs, despite the company not meeting its EBITDA target due to challenges faced during the year.

Other

$710.64K

Board Justification

Other compensation includes a deferred compensation payment related to previous employment, health benefits, and other perquisites.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2021 as part of the compensation package for Labeed Diab.

Performance Metrics

The performance metrics for determining compensation included the company's EBITDA targets and overall performance during a challenging year.

Other ATI Physical Therapy CEOs

Here are other CEOs of ATI Physical Therapy

Sharon Vitti

CEO of ATI Physical Therapy

April 2022 - Present